500-Bed Smart Hospital Project, Thu Duc City
Reference SI-027
Location Thu Duc City, Ho Chi Minh City
Operating history Not disclosed
Status Project / greenfield
Revenue Not disclosed
Asking price US$25MVND 650bn
Stake offered 100%
Deal type Majority or full sale Overview Greenfield smart-hospital project on titled healthcare land in an urban area of HCMC, designed to Japanese healthcare standards.
Key facts and assets 21,625 m² of land with a land-use certificate for healthcare facilities 20 floors plus 2 basements; gross floor area over 173,000 m²; 500 beds (phase 1: 300) Total investment about VND 4,452bn; IRR 16.9% against WACC 10.1%; NPV about VND 3,333bn; payback about 8.5 years Planned volumes: 912,500 outpatient visits and 18,250 surgeries a year; about 750 doctors and staff Focus on cardiology, endocrinology, emergency care, rehabilitation, geriatrics and health screening Who it suits Domestic and foreign healthcare groups, healthcare real-estate and infrastructure funds, and financial institutions.
Transaction sought Sale of 100% of the project or shares at VND 650bn.
USD figures are indicative, converted at about VND 25,500 per US$. Figures come from the seller and are unaudited.
Similar opportunities SI-024 Nationwide (HQ Ho Chi Minh City) Healthcare & Pharma
Closed-loop postnatal care brand: spa chain, herbal cosmetics workshop and its own training academy, expanding by franchise.
Revenue Not disclosed
Asking US$0.39M VND 10bn · for 30%
Stake 30%
SI-025 Nationwide Healthcare & Pharma
Two-company structure: exclusive importer of US and Australian supplements plus a distributor covering all 63 provinces.
Revenue US$3.3M
Asking US$8.2M
Stake 100%
SI-026 Mekong Delta (next to HCMC) Healthcare & Pharma
Twenty-seven-year-old pharmacy group with a 37% regional market share, over 90% cash sales and no debt.
Revenue US$2.7M VND 70bn
Asking US$1.8M
Stake 100%
SI-001 Ho Chi Minh City Manufacturing & Packaging
Established PET packaging plant in an HCMC industrial park, running at about 70% of capacity, with B2B customers at home and in the US. The owner is relocating abroad and offers 100% of the business.
Revenue US$6.9M VND 175bn
Asking Not disclosed
Stake 100%
Buyers looking in this sector BM-02 Vietnam Private equity / venture fund Healthcare & Pharma
Domestic PE fund prioritising operating hospitals, with additional interest in retail, education, technology and logistics.
Min. revenue ≥ US$5M
Ticket US$5–20M
Stake 50–100%
BM-08 United States Private equity / venture fund Healthcare & Pharma
Long-established US investor taking minority equity of under 50% in health and life-sciences ventures.
Min. revenue —
Ticket US$0.5–5M
Stake Up to 49%
BM-15 International Strategic buyer Healthcare & Pharma
Acquirer expanding a healthcare system with an international orientation, preferring control or full ownership.
Min. revenue —
Ticket —
Stake 51–100%